Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report

BACKGROUND: Patients with relapsed/refractory acute myeloid leukemia after hematopoietic stem cell transplantation (HSCT) have a poor prognosis, with a 2-year survival rate of 14%. The optimal treatment for these patients remains unclear. To treat these patients, we designed a new salvage regimen co...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Mengqi, Hu, Yongxian, Wu, Wenjun, Luo, Yi, Tan, Yamin, Yu, Jian, Jin, Aiyun, Yang, Luxin, Huang, He, Wei, Guoqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423868/
https://www.ncbi.nlm.nih.gov/pubmed/30885156
http://dx.doi.org/10.1186/s12885-019-5464-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423868/
https://www.ncbi.nlm.nih.gov/pubmed/30885156
http://dx.doi.org/10.1186/s12885-019-5464-0

Ejemplares similares